Takip et
Ann Vos
Ann Vos
Janssen
its.jnj.com üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance
S Hare, AM Vos, RF Clayton, JW Thuring, MD Cummings, P Cherepanov
Proceedings of the National Academy of Sciences 107 (46), 20057-20062, 2010
3552010
A theoretical study of the alkylation reaction of toluene with methanol catalyzed by acidic mordenite
AM Vos, X Rozanska, RA Schoonheydt, RA Van Santen, F Hutschka, ...
Journal of the American Chemical Society 123 (12), 2799-2809, 2001
2342001
Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors
O Goethals, R Clayton, M Van Ginderen, I Vereycken, E Wagemans, ...
Journal of virology 82 (21), 10366-10374, 2008
1892008
Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor
R Spurny, S Debaveye, A Farinha, K Veys, AM Vos, T Gossas, J Atack, ...
Proceedings of the National Academy of Sciences 112 (19), E2543-E2552, 2015
1192015
Reactivity descriptors and rate constants for electrophilic aromatic substitution: acid zeolite catalyzed methylation of benzene and toluene
AM Vos, KHL Nulens, F De Proft, RA Schoonheydt, P Geerlings
The Journal of Physical Chemistry B 106 (8), 2026-2034, 2002
1172002
1, 4-Oxazine β-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads
FJR Rombouts, G Tresadern, O Delgado, C Martínez-Lamenca, ...
Journal of Medicinal Chemistry 58 (20), 8216-8235, 2015
762015
Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors …
O Goethals, A Vos, M Van Ginderen, P Geluykens, V Smits, D Schols, ...
Virology 402 (2), 338-346, 2010
702010
Minisci-photoredox-mediated α-heteroarylation of N-protected secondary amines: remarkable selectivity of azetidines
C Bosset, H Beucher, G Bretel, E Pasquier, L Queguiner, C Henry, A Vos, ...
Organic letters 20 (19), 6003-6006, 2018
692018
Structure-based site of metabolism prediction for cytochrome P450 2D6
SLC Moors, AM Vos, MD Cummings, H Van Vlijmen, A Ceulemans
Journal of medicinal chemistry 54 (17), 6098-6105, 2011
602011
1a/1b subtype profiling of nonnucleoside polymerase inhibitors of hepatitis C virus
O Nyanguile, B Devogelaere, L Vijgen, W Van den Broeck, F Pauwels, ...
Journal of virology 84 (6), 2923-2934, 2010
472010
Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV)
K Vandyck, G Rombouts, B Stoops, A Tahri, A Vos, W Verschueren, Y Wu, ...
Journal of Medicinal Chemistry 61 (14), 6247-6260, 2018
462018
Reactivity descriptors and rate constants for acid zeolite catalyzed ethylation and isopropylation of benzene
AM Vos, RA Schoonheydt, F De Proft, P Geerlings
The Journal of Physical Chemistry B 107 (9), 2001-2008, 2003
432003
Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor
O Goethals, M Van Ginderen, A Vos, MD Cummings, K Van Der Borght, ...
Antiviral research 91 (2), 167-176, 2011
402011
Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype AH clinical isolates and core site-directed mutants in vitro
JM Berke, Y Tan, T Verbinnen, P Dehertogh, K Vergauwen, A Vos, O Lenz, ...
Antiviral research 144, 205-215, 2017
312017
A computational and conceptual DFT approach to the kinetics of acid zeolite catalyzed electrophilic aromatic substitution reactions
P Geerlings, AM Vos, RA Schoonheydt
Journal of Molecular Structure: THEOCHEM 762 (1-3), 69-78, 2006
242006
Evaluation of a series of β-secretase 1 inhibitors containing novel heteroaryl-fused-piperazine amidine warheads
D Oehlrich, A Peschiulli, G Tresadern, M Van Gool, JA Vega, AI De Lucas, ...
ACS Medicinal Chemistry Letters 10 (8), 1159-1165, 2019
222019
NO 2 disproportionation for the IR characterisation of basic zeolites
O Marie, N Malicki, C Pommier, P Massiani, A Vos, R Schoonheydt, ...
Chemical communications, 1049-1051, 2005
212005
DFT study on the electrophilic aromatic substitution catalyzed by Lewis acids
AM Vos, RA Schoonheydt, F De Proft, P Geerlings
Journal of Catalysis 220 (2), 333-346, 2003
212003
Fragment binding to β-secretase 1 without catalytic aspartate interactions identified via orthogonal screening approaches
FJR Rombouts, R Alexander, E Cleiren, A De Groot, M Carpentier, ...
ACS omega 2 (2), 685-697, 2017
192017
NO+: Infrared probe for basic zeolites
F Thibault-Starzyk, O Marie, N Malicki, A Vos, R Schoonheydt, ...
Studies in Surface Science and Catalysis 158, 663-670, 2005
182005
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20